Literature DB >> 10903891

Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones.

A Dagnino-Subiabre1, B K Cassels, S Baez, A S Johansson, B Mannervik, J Segura-Aguilar.   

Abstract

Human glutathione transferase M2-2 prevents the formation of neurotoxic aminochrome and dopachrome by catalyzing the conjugation of dopamine and dopa o-quinone with glutathione. NMR analysis of dopamine and dopa o-quinone-glutathione conjugates revealed that the addition of glutathione was at C-5 to form 5-S-glutathionyl-dopamine and 5-S-glutathionyl-dopa, respectively. Both conjugates were found to be resistant to oxidation by biological oxidizing agents such as O(2), H(2)O(2), and O(*-)(2), and the glutathione transferase-catalyzed reaction can therefore serve a neuroprotective antioxidant function. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903891     DOI: 10.1006/bbrc.2000.3087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Glutathione conjugates with dopamine-derived quinones to form reactive or non-reactive glutathione-conjugates.

Authors:  Zhi Dong Zhou; Tit Meng Lim
Journal:  Neurochem Res       Date:  2010-08-19       Impact factor: 3.996

2.  Characterization of the monophenolase activity of tyrosinase on betaxanthins: the tyramine-betaxanthin/dopamine-betaxanthin pair.

Authors:  Fernando Gandía-Herrero; Josefa Escribano; Francisco García-Carmona
Journal:  Planta       Date:  2005-06-21       Impact factor: 4.116

3.  Minor modifications of the C-terminal helix reschedule the favored chemical reactions catalyzed by theta class glutathione transferase T1-1.

Authors:  Abeer Shokeer; Bengt Mannervik
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.

Authors:  Carlos Cuevas; Sandro Huenchuguala; Patricia Muñoz; Monica Villa; Irmgard Paris; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2014-11-18       Impact factor: 3.911

Review 5.  Racial disparities, cancer and response to oxidative stress.

Authors:  Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew
Journal:  Adv Cancer Res       Date:  2019-04-23       Impact factor: 6.242

Review 6.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

7.  S-Glutathionyl-(chloro)hydroquinone reductases: a novel class of glutathione transferases.

Authors:  Luying Xun; Sara M Belchik; Randy Xun; Yan Huang; Huina Zhou; Emiliano Sanchez; Chulhee Kang; Philip G Board
Journal:  Biochem J       Date:  2010-05-27       Impact factor: 3.857

8.  Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction.

Authors:  Sandro Huenchuguala; Patricia Muñoz; Patricio Zavala; Mónica Villa; Carlos Cuevas; Ulises Ahumada; Rebecca Graumann; Beston F Nore; Eduardo Couve; Bengt Mannervik; Irmgard Paris; Juan Segura-Aguilar
Journal:  Autophagy       Date:  2014-01-14       Impact factor: 16.016

9.  Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology.

Authors:  P David Josephy
Journal:  Hum Genomics Proteomics       Date:  2010-06-13

10.  Genetic modification of the association of paraquat and Parkinson's disease.

Authors:  Samuel M Goldman; Freya Kamel; G Webster Ross; Grace S Bhudhikanok; Jane A Hoppin; Monica Korell; Connie Marras; Cheryl Meng; David M Umbach; Meike Kasten; Anabel R Chade; Kathleen Comyns; Marie B Richards; Dale P Sandler; Aaron Blair; J William Langston; Caroline M Tanner
Journal:  Mov Disord       Date:  2012-10-08       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.